Clinicaltrials.gov identifier:
NCT03581357 (https://clinicaltrials.gov/show/NCT03581357)
Quality of Life
Study Contact Information:
For questions about the study, contact Erin O’Carroll Bantum, PhD by phone at (808) 441-3491 or by email.
The University of Hawai‘i Cancer Center is running a mobile app study to see how it impacts cancer-related neuropathy. We are asking people who have been diagnosed with cancer, have finished primary treatment and are experiencing neuropathy if they would like to use a mobile app for mindfulness meditation to see if it helps their neuropathy.
Interested participants will be asked to follow the link for either anxiety OR neuropathy and to participate in only one of the studies, one time only. Upon enrollment, you will randomly be assigned to begin using the mobile app either immediately or after eight weeks. You will be asked to complete online questionnaires about your well-being upon your initial enrollment, 8 weeks later, and 16 weeks later.
*Neuropathy is defined as a sensation of numbness, prickling or tingling that can include one or more of the following:
This study is being run by the University of Hawai‘i Cancer Center. It is conducted online and can be completed from anywhere in the U.S.
Erin O'Carroll Bantum, PhD
University of Hawai‘i Cancer Center
Honolulu, HI
The neuropathy arm of the study is open to men and women if they:
People are excluded if they do not meet the listed eligibility criteria.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.